MattisonKim (Mattie)

Associate

Minneapolis + 1.612.217.8851

Mattie Kim represents policyholders in pursuing insurance claims and in litigation matters. She has been involved in complex insurance coverage claims relating to various types of coverage, including commercial general liability, property, representations and warranties, and directors and officers liability insurance. She has experience in many aspects of litigation, including case management, discovery, briefing and motion practice, and trial preparation. In addition, she has experience in transactional M&A and private equity insurance placements.

Mattie also maintains an active pro bono practice and represents low-income tenants in eviction proceedings, repair actions, and eviction expungement motions. As lead trial counsel, Mattie successfully secured a housing repair order and rent abatement for a tenant in Minneapolis. She has achieved numerous positive results for tenants through pretrial negotiation and settlement.

Experience

  • Milliken & Company acquires Borchers from The Jordan CompanyJones Day advised Milliken & Company in its acquisition of Borchers Group Limited, a global specialty chemicals company known for its innovative high-performance coating additives and specialty catalyst solutions, from The Jordan Company, L.P.
  • Morgan Stanley Capital Partners portfolio company acquires iMark MoldingJones Day represented Morgan Stanley Capital Partners in connection with the acquisition and related financing by portfolio company Comar Holding Company, LLC of iMark Molding, LLC ("iMark") from the original iMark founders.
  • Seal for Life acquires Flame Control Coatings, Highland International, LifeLast, and US CoatingsJones Day advised Arsenal Capital Partners ("ACP") on the four acquisitions by portfolio company Seal for Life of Flame Control Coatings, Highland International, LifeLast, and US Coatings, manufacturers of protective coating technologies.
  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • Shiseido acquires Drunk Elephant™ for $845 millionJones Day advised Shiseido Americas Corporation in its $845 million acquisition of Drunk Elephant™.
  • HOERBIGER Group acquires Deublin CompanyJones Day advised HOERBIGER Group, a privately-held industrial company headquartered in Switzerland, on the acquisition of Deublin Company, the leading manufacturer of rotating unions in the world.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.